Table 2.
Means and SD for Six Groups | Statistical Analysis Results | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
70 mg groups |
100 mg groups |
contrasts, 70 mg groups |
contrasts, 100 mg groups |
|||||||||
NC | Coc | Split | NC | Coc | Split | NC vs C | C vs S | NC vs S | NC vs C | C vs S | NC vs S | |
Quantitative benzoylecgonine | ||||||||||||
Mean BZE ng/mL | 55,842 | 44,183 | 42,981 | 66,313 | 42,397 | 56,717 | p = .02 | n.s. | n.s. | p<.003 | n.s. | p<.04 |
SD | 47,258 | 46,550 | 47,316 | 45,735 | 47,264 | 46,786 | ||||||
Longest duration of simultaneous abstinence | ||||||||||||
Mean weeks | 0.91 | 1.26 | 2.00 | 0.71 | 2.17 | 2.71 | n.s. | n.s. | n.s. | p<.04 | n.s. | p<.02 |
SD | 2.33 | 1.93 | 3.36 | 1.25 | 3.59 | 4.21 | ||||||
Self-reported cocaine use | ||||||||||||
Mean uses/day | 0.39 | 0.20 | 0.32 | 0.40 | 0.25 | 0.29 | p=.003 | p=.033 | n.s. | p=.012 | n.s. | p<.009 |
SD | 0.27 | 0.27 | 0.27 | 0.27 | 0.28 | 0.29 | ||||||
Quality of life - SAS-SR | ||||||||||||
Mean score, family | 1.79 | 1.51 | 1.39 | 1.54 | 1.54 | 1.34 | p=.082 | n.s. | p=.014 | n.s. | n.s. | n.s. |
SD | 0.68 | 0.67 | 0.69 | 0.69 | 0.70 | 0.71 | ||||||
Mean score, financial | 2.39 | 1.99 | 2.18 | 2.22 | 1.89 | 1.09 | p=.09 | n.s. | n.s. | n.s. | n.s. | n.s. |
SD | 1.04 | 1.03 | 1.02 | 1.05 | 1.09 | 1.01 |
NC - noncontingent; C - cocaine contingency; S - split contingency; BZE - benzoylecgonine; n.s. - not significant, p > .10.